← Back to headlines

Daraxonrasib Demonstrates First-Line Activity With/Without Chemotherapy in Metastatic PDAC

This story is reported by OncLive. Read what other outlets are saying below, then open the original report for full details.

Daraxonrasib Demonstrates First-Line Activity With/Without Chemotherapy in Metastatic PDAC · NabkaNews